Clinical Trial: A Clinical Study Evaluating the Efficacy and Safety of SHR-1139 Injection in Adult Patients With Ulcerative Pyoderma Gangrenosum

U.S., Jan. 14 -- ClinicalTrials.gov registry received information related to the study (NCT07337564) titled 'A Clinical Study Evaluating the Efficacy and Safety of SHR-1139 Injection in Adult Patients With Ulcerative Pyoderma Gangrenosum' on Dec. 17, 2025.

Brief Summary: This study was designed to assess the therapeutic efficacy and safety of SHR-1139 Injection in adult patients with ulcerative pyoderma gangrenosum.

Study Start Date: Feb. 01

Study Type: INTERVENTIONAL

Condition: Pyoderma Gangrenosum

Intervention: DRUG: SHR-1139 Injection

SHR-1139 Injection

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Shandong First Medical University

Disclaimer: Curated by HT Syndication....